ING Groep NV reduced its position in HCA Holdings, Inc. (NYSE:HCA) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,428 shares of the company’s stock after selling 91 shares during the period. ING Groep NV’s holdings in HCA Holdings were worth $1,956,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. James Investment Research Inc. purchased a new position in shares of HCA Holdings during the first quarter worth about $226,000. State of Alaska Department of Revenue purchased a new position in shares of HCA Holdings during the first quarter worth about $381,000. Nisa Investment Advisors LLC increased its position in shares of HCA Holdings by 6.0% in the first quarter. Nisa Investment Advisors LLC now owns 94,499 shares of the company’s stock worth $8,409,000 after buying an additional 5,330 shares during the period. Boston Advisors LLC increased its position in shares of HCA Holdings by 0.6% in the first quarter. Boston Advisors LLC now owns 6,212 shares of the company’s stock worth $553,000 after buying an additional 37 shares during the period. Finally, DnB Asset Management AS increased its position in shares of HCA Holdings by 23.0% in the first quarter. DnB Asset Management AS now owns 34,744 shares of the company’s stock worth $3,092,000 after buying an additional 6,500 shares during the period. Hedge funds and other institutional investors own 75.69% of the company’s stock.
Shares of HCA Holdings, Inc. (NYSE:HCA) opened at 77.79 on Friday. The stock has a 50 day moving average of $82.70 and a 200 day moving average of $84.29. HCA Holdings, Inc. has a 1-year low of $67.00 and a 1-year high of $91.03. The company has a market cap of $28.10 billion, a price-to-earnings ratio of 10.43 and a beta of 0.67.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.80 by $0.05. The company had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. HCA Holdings’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.66 EPS. On average, equities analysts forecast that HCA Holdings, Inc. will post $7.17 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “ING Groep NV Sells 91 Shares of HCA Holdings, Inc. (NYSE:HCA)” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://stocknewstimes.com/2017/08/18/ing-groep-nv-has-1-96-million-stake-in-hca-holdings-inc-nysehca-updated-updated.html.
HCA has been the topic of a number of research reports. Zacks Investment Research downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a research report on Friday, July 14th. BidaskClub downgraded shares of HCA Holdings from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Argus initiated coverage on shares of HCA Holdings in a research report on Wednesday, June 28th. They set a “buy” rating and a $100.00 target price on the stock. Leerink Swann upgraded shares of HCA Holdings from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $92.00 to $100.00 in a research report on Tuesday, June 6th. Finally, Morgan Stanley initiated coverage on shares of HCA Holdings in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 target price on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $92.88.
In other news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $79.88, for a total value of $171,742.00. Following the completion of the transaction, the insider now owns 12,363 shares of the company’s stock, valued at approximately $987,556.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Jana Joustra Davis sold 54,689 shares of HCA Holdings stock in a transaction dated Tuesday, May 23rd. The stock was sold at an average price of $82.35, for a total value of $4,503,639.15. Following the completion of the transaction, the senior vice president now directly owns 107,892 shares of the company’s stock, valued at approximately $8,884,906.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 132,202 shares of company stock valued at $11,155,094. 2.90% of the stock is owned by insiders.
About HCA Holdings
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
